Omeros (Seattle, USA) is a biopharmaceutical company advancing a pipeline of product candidates for use in orthopedics, rheumatology, urology, cardiovascular medicine, general surgery and pain management. Omeros' perioperative technology consists of combinations of agents, generic or proprietary, delivered preemptively and locally during surgical and medical procedures.

http://www.omeros.com/